Latest news
Orforglipron vs. Tirzepatide: What Are the Major Differences? - GoodRxGoodRx · Sun, 09 Aug 2026 07:36:16 GMTFDA approves Eli Lilly’s weight-loss pill; Judge revokes citizenship over stolen medical secrets for China; new COVID-19 ‘Cicada’ variant spreads to 25 states – Morning Medical Update - Medical EconomicsMedical Economics · Sun, 09 Aug 2026 02:13:19 GMTEli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 22:50:00 GMTEli Lilly offers new weight loss drug to some patients before FDA approval - LiveNOW from FOXLiveNOW from FOX · Fri, 07 Aug 2026 15:20:40 GMTLilly Expands Retatrutide Access Amid Doctor Pushback - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Wed, 05 Aug 2026 20:37:18 GMTSome patients to score new super-effective 'Triple G' weight loss drug — before FDA approval - New York PostNew York Post · Wed, 05 Aug 2026 15:20:00 GMTFDA Approved Weight Loss Drugs: What Works, What Doesn't, and How to Choose Wisely *KdZneLjqz* - Diario ASDiario AS · Wed, 05 Aug 2026 01:55:51 GMTEli Lilly to Offer Experimental GLP-1 Retatrutide for Compassionate Use — Who Qualifies? - Everyday HealthEveryday Health · Wed, 05 Aug 2026 00:21:28 GMT